This inventor holds 1 USPTO granted patent. Top assignee: Delalande S.a.. Active years: 1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991
Title: Jean-Marc M Guiraudie: Innovator in Oxazoloquinoline Compounds
Introduction
Jean-Marc M Guiraudie is a notable inventor based in Paris, France. He has made significant contributions to the field of medicinal chemistry, particularly through his work on oxazoloquinoline compounds. His innovative approach has led to advancements in therapeutic applications, showcasing his expertise and dedication to improving healthcare.
Latest Patents
Jean-Marc holds a patent for "Oxazoloquinoline compounds and therapeutic application thereof." This invention relates to tricyclic carbamates that comply with a specific formula, where n can be 0, 1, or 2. His work in this area has the potential to impact various therapeutic applications, highlighting the importance of his research.
Career Highlights
Throughout his career, Jean-Marc has been associated with Delalande S.A., where he has furthered his research and development efforts. His commitment to innovation is evident in his patent, which reflects his ability to translate complex scientific concepts into practical applications.
Collaborations
Jean-Marc has collaborated with esteemed colleagues, including Alain J Renaud and Alain R Schoofs. These partnerships have enriched his research and contributed to the advancement of their shared goals in the field of medicinal chemistry.
Conclusion
Jean-Marc M Guiraudie is a distinguished inventor whose work on oxazoloquinoline compounds exemplifies the intersection of innovation and healthcare. His contributions continue to pave the way for future advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile